Rating History for Vanda Pharmaceuticals (VNDA) by Oppenheimer
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/23/2026 | Les Sulewski | New Coverage | Outperform (N/A) |
10.00 (N/A) |
5.21 (4.03) |
-22.65% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/23/2026 | Les Sulewski | New Coverage | Outperform (N/A) |
10.00 (N/A) |
5.21 (4.03) |
-22.65% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||